Physician profile
James P Corrigan
NPI 1538157680
$1,269.14
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $239 · 2021: $433 · 2022: $16.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $201.88 | 2019-2021 | |
| Abbvie INC. | $184.40 | 2019-2021 | |
| Novo Nordisk INC | $172.37 | 2019-2021 | |
| Lilly USA, LLC | $90.89 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $85.30 | 2019-2021 | |
| Amarin Pharma, INC. | $56.96 | 2019-2020 | |
| Medtronic Minimed, INC. | $53.77 | 2019 | |
| Medtronic, INC. | $48.38 | 2021 | |
| Amgen INC. | $43.14 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $41.36 | 2019 | |
| Jazz Pharmaceuticals INC. | $35.08 | 2020-2021 | |
| Eisai INC. | $33.72 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.97 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $29.18 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $19.50 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $18.88 | 2019 | |
| Astellas Pharma US INC | $18.02 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.25 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.29 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.34 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.11 | 2021 | |
| Glaxosmithkline, LLC. | $14.45 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.75 | 2019 | |
| Pfizer INC. | $11.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Corrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.